Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

NCT02599454 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Stage I Non-Small Cell Lung Cancer

Interventions

DRUG: Atezolizumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Megan Daly, MD

Collaborators

[object Object]